Our Designated Centers of Excellence
National accreditations and third-party certifications of excellence attest to UNC Neurology’s expertise and multidisciplinary care.
UNC Stroke Center
The UNC Medical Center has a strong track record of quality and excellence in stroke care and has maintained the Joint Commission Disease-Specific Certification as a Primary Stroke Center since its founding in 2004. In 2013, the UNC Medical Center became the first hospital in the Southeast to receive the Joint Commission Advanced Certification as a Comprehensive Stroke Center, confirming UNC Medical Center’s position as a national leader in stroke care.
The UNC Comprehensive Stroke Center has received the American Heart Association/American Stroke Association Get With The Guidelines Gold Plus Achievement Award and is recognized in the American Heart Association/American Stroke Association Target Stroke Elite Plus Honor Roll – the highest level possible. Hospitals receiving the Gold Plus award have maintained an aggressive goal of treating stroke patients with 85% or higher compliance in core standards of care as outlined by the American Heart Association/American Stroke Association for 12 consecutive months and have demonstrated 75% compliance in seven out of ten additional stroke quality measures during the 12-month period.
UNC Epilepsy Center
The UNC Epilepsy Center is designated as a level 4 center by National Association of Epilepsy Centers (NAEC), which is the highest designation representing the most complex forms of diagnostic evaluations and treatment options. A level 4 center provides the more complex forms of intensive neurodiagnostic monitoring, as well as more extensive medical, neuropsychological, and psychosocial treatment. Level 4 centers also offer a complete evaluation for epilepsy surgery, including intracranial electrodes and a broad range of surgical procedures for epilepsy.
Movement Disorders Center
The Movement Disorders Center at The University of North Carolina Hospitals is a designated National Parkinson Foundation Center of Excellence. In 2004, the UNC School of Medicine and UNC Hospitals became the first medical center in North Carolina to join the ranks of only 43 National Parkinson’s Foundation (NPF) Centers of Excellence worldwide. Specially-marked NPF Centers of Excellence feature comprehensive care teams that meet every patient need and provide access to clinical trials and experimental therapies.
CurePSP Center of Care
The CurePSP organization is dedicated to improving care and advancing research for people diagnosed with the rare atypical parkinsonism disorders, progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). The CurePSP Center of Care designation recognizes UNC as a premier center that is committed to providing excellent care to patients with these conditions. Additionally, it highlights our commitment to research and education in these rare conditions.
Neurofibromatosis Comprehensive Clinic
The Neurofibromatosis Clinic Network (NFCN) was established by the Children’s Tumor Foundation (CTF) in 2007 to standardize and raise the level of neurofibromatosis (NF) clinical care nationally and integrate research into clinical care practices. The NFCN is the first nationwide network dedicated to improving clinical care and establishing best practices for treating those living with NF. The NF Clinic Network recognizes clinics that provide comprehensive medical care to individuals with NF, foster patient education, and encourage participation in clinical research trials and the NF registry. There are currently 50 NF Clinics in the NFCN that have demonstrated their ability to provide specialty care to NF patients and their families.
Muscular Dystrophy Association Clinic
(includes ALS and Myasthenia Gravis Clinics)
Muscular Dystrophy Association (MDA) Care Centers offer families best-in-class, comprehensive care from a wide variety of health care specialists at one location on the same day. Centers provide early diagnosis, highly specialized care and access to promising clinical trials help ensure the best possible outcomes for individuals and families facing muscular dystrophy, ALS and related muscle-debilitating diseases. MDA clinics utilize a multidisciplinary team approach, meaning individuals can see knowledgeable health care specialists from a variety of disciplines, all at one location.
UNC Memory Disorders Program
UNC Neurology was named a LBDA Research Center of Excellence (RCOE) by the Lewy Body Dementia Association (LBDA), the leading advocacy group dedicated to raising awareness and advancing research about Lewy body dementia (LBD). This collaboration features 24 preeminent academic medical research centers across the United States, coordinated by Mayo Clinic. The LBDA RCOE program provides a centralized, coordinated research resource, supporting an expanded effort in conducting clinical trials related to LBD while helping to provide expert clinical care for patients, families and caregivers.
A primary mission of the Charcot-Marie-Tooth Association (CMTA) is to improve the quality of life for those with CMT. One means of accomplishing this directive is by sponsoring patient-centric, multi-disciplinary CMT clinics, staffed by some of the highest quality CMT clinicians and researchers in the world. Through these CMTA Centers of Excellence, patients affected by CMT can be assured of receiving comprehensive care by a team of CMT experts. UNC Neurology is proud to be one of only 24 CMTA’s national centers.
UNC Neurology is proud to be a Hereditary Neuropathy Foundation Charcot-Marie-Tooth Center of Excellence. Designated centers demonstrate excellence in clinical care and research, and collaborate with the Hereditary Neuropathy Foundation to serve as a Charcot-Marie-Tooth patient community hub for clinical care, community engagement, research, training and education.
UNC Neurology is designated as a GBS | CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, and other inflammatory peripheral neuropathies. Designated centers demonstrate a consistently high level of patient care, expertise, treatments, facilities, and research capabilities. Founded in 1980, GBS/CIDP Foundation International has 35,000 members worldwide and supports 44 global centers of excellence.